Wednesday, February 10, 2010, 2:06PM AEST - The Australian Stockmarket closes in 1 hour and 59 minutes.
To create a watchlist or portfolio of shares, Register

Caliper Life Sciences, Inc. (CALP)

7:59AM AEST: 3.15 USD   0.00 (0.00%)  
 MORE ON CALP 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Caliper Life Sciences Inc (NGM:CALP) Delayed quote dataEdit
Last Trade:3.15 USD
Trade Time: 7:59AM AEST
Change: 0.00 (0.00%)
Prev Close:3.15
Open:3.19
Bid:2.69 x 1500
Ask:3.64 x 100
1y Target Est:3.00
Day's Range:3.10 - 3.20
52wk Range:0.76 - 3.60
Volume:33,913
Avg Vol (3m):64,336.5
Market Cap:154.45M
P/E (ttm):N/A
EPS (ttm):-1.24
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add CALP to Portfolio   Download Data

 HEADLINES 
RBC Capital Markets Expert Equity Analyst Sees "Shopping Spree" For Acquisitions Of Home Health Care And Diagnostics Companies In 2010 To 2011 Time Frame
Wall Street Transcript (Wed, Feb 3)
Caliper Life Sciences Introduces Sciclone(R) G3 Liquid Handler
PR Newswire (Tue, Jan 26)
Caliper Integrated Robotic System Featured in TIME Magazine's Top 10 Scientific Discoveries of 2009
PR Newswire (Fri, Jan 22)
LaBranche, Caliper Life Sciences: Biggest Price Gainers (LAB, CALP)
at The Wall Street Journal Online (Fri, Jan 15)
[$$] Waiting On Intel
at RealMoney by TheStreet.com (Fri, Jan 15)
CALIPER LIFE SCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure
EDGAR Online (Fri, Jan 15)
Caliper Life Sciences Announces Preliminary Results for the Fourth Quarter and 2009
PR Newswire (Thu, Jan 14)
Caliper Licenses Microfluidics IP to Becton Dickinson
PR Newswire (Tue, Jan 12)
Caliper Life Sciences to Present at the 28th Annual J.P. Morgan Healthcare Conference
PR Newswire (Wed, Jan 6)
CALIPER LIFE SCIENCES INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off
EDGAR Online (Fri, Dec 18)
More Headlines for CALP...

 ANALYST 
EPS Est (next year) (Dec-09) :-0.18
EPS Est (in 2 years) (Dec-10) :-0.11
Avg Rec (current)*:1.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Caliper Life Sciences, Inc. develops and sells products and services to pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices